Cargando…
Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma is the most common form of pancreatic cancer. It is known for low life expectancies after diagnosis and very limited treatment options. The identification of new therapeutic molecular targets is urgent as it might allow faster development of new treat...
Autores principales: | Beirith, Iris, Renz, Bernhard W., Mudusetti, Shristee, Ring, Natalja Sergejewna, Kolorz, Julian, Koch, Dominik, Bazhin, Alexandr V., Berger, Michael, Wang, Jing, Angele, Martin K., D’Haese, Jan G., Guba, Markus O., Niess, Hanno, Andrassy, Joachim, Werner, Jens, Ilmer, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198055/ https://www.ncbi.nlm.nih.gov/pubmed/34070805 http://dx.doi.org/10.3390/cancers13112703 |
Ejemplares similares
-
Textbook outcome in hepato-pancreato-biliary surgery: systematic review
por: Pretzsch, Elise, et al.
Publicado: (2022) -
WNT enhancing signals in pancreatic cancer are transmitted by LGR6
por: Wang, Jing, et al.
Publicado: (2023) -
The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors
por: Kolorz, Julian, et al.
Publicado: (2021) -
Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
por: Renz, Bernhard W., et al.
Publicado: (2017) -
Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis
por: Pretzsch, E., et al.
Publicado: (2021)